一名患有低度非霍奇金淋巴瘤（NHL）的患者，在接受2-氯脱氧腺苷（CdA）治疗后，其鞍上继发肿块完全消退。 - Suppr | 超能文献

Complete regression of a suprasellar secondary mass in a patient with low-grade non-Hodgkin's lymphoma (NHL) treated with 2-chlorodeoxyadenosine (CdA).

作者信息

deCataldo F, Baudo F, Ottonelli C, Italia C, Valdagni R

出版信息

Am J Hematol. 1998 Mar;57(3):258-9. doi: 10.1002/(sici)1096-8652(199803)57:3<258::aid-ajh15>3.0.co;2-6.

DOI:10.1002/(sici)1096-8652(199803)57:3<258::aid-ajh15>3.0.co;2-6

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Complete regression of a suprasellar secondary mass in a patient with low-grade non-Hodgkin's lymphoma (NHL) treated with 2-chlorodeoxyadenosine (CdA).一名患有低度非霍奇金淋巴瘤（NHL）的患者，在接受2-氯脱氧腺苷（CdA）治疗后，其鞍上继发肿块完全消退。

Am J Hematol. 1998 Mar;57(3):258-9. doi: 10.1002/(sici)1096-8652(199803)57:3<258::aid-ajh15>3.0.co;2-6.

2

Fewer infections, but maintained antitumor activity with lower-dose versus standard-dose cladribine in pretreated low-grade non-Hodgkin's lymphoma.在预处理的低级别非霍奇金淋巴瘤中，感染减少，但与标准剂量的克拉屈滨相比，低剂量克拉屈滨仍保持抗肿瘤活性。

J Clin Oncol. 1998 Mar;16(3):850-8. doi: 10.1200/JCO.1998.16.3.850.

3

Activity of 2-chlorodeoxyadenosine (Cladribine) in 2-hour intravenous infusion in 94 previously treated patients with low grade non-Hodgkin's lymphoma.94例先前接受过治疗的低度非霍奇金淋巴瘤患者静脉输注2小时2-氯脱氧腺苷（克拉屈滨）的活性。

Leuk Lymphoma. 1997 Jun;26(1-2):99-105. doi: 10.3109/10428199709109163.

4

Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced, indolent non-Hodgkin's lymphoma.

Cancer. 1999 Jan 1;85(1):242-3. doi: 10.1002/(sici)1097-0142(19990101)85:1<242::aid-cncr34>3.0.co;2-r.

5

Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced, indolent non-Hodgkin's lymphoma.2-氯脱氧腺苷用于既往治疗过的晚期惰性非霍奇金淋巴瘤的长期随访及晚期并发症

Cancer. 1998 Mar 1;82(5):957-64.

6

Cladribine in the treatment of advanced relapsed or refractory low and intermediate grade non-Hodgkin's lymphoma.

Cancer. 1998 Dec 1;83(11):2370-6. doi: 10.1002/(sici)1097-0142(19981201)83:11<2370::aid-cncr17>3.0.co;2-m.

7

Cladribine for untreated or early low-grade non-Hodgkin's lymphoma.克拉屈滨用于未经治疗的或早期低度非霍奇金淋巴瘤。

Leuk Lymphoma. 1998 Aug;30(5-6):573-81. doi: 10.3109/10428199809057569.

8

2-Chlorodeoxyadenosine is an active salvage therapy in advanced indolent non-Hodgkin's lymphoma.2-氯脱氧腺苷是晚期惰性非霍奇金淋巴瘤的一种有效的补救疗法。

J Clin Oncol. 1994 Apr;12(4):788-92. doi: 10.1200/JCO.1994.12.4.788.

9

Cladribine combined with rituximab (R-2-CdA) therapy is an effective salvage therapy in relapsed or refractory indolent B-cell non-Hodgkin lymphoma.克拉屈滨联合利妥昔单抗（R-2-CdA）治疗方案是复发或难治性惰性 B 细胞非霍奇金淋巴瘤的有效挽救治疗方法。

Eur J Haematol. 2011 Feb;86(2):117-23. doi: 10.1111/j.1600-0609.2010.01552.x. Epub 2010 Dec 29.

10

Cladribine in the treatment of low-grade non-Hodgkin's lymphoma.

Semin Hematol. 1996 Jan;33(1 Suppl 1):34-9.